Carla Maran l Palladium - Nov 18 2026
The Silent Pandemic: Sustaining the Fight Against AMR

Medicines are losing their ability to treat infections. Antimicrobial resistance (AMR) rarely makes headlines in the way an outbreak does, but the consequences are already being felt in hospitals, clinics and communities around the world.

Antimicrobial resistance, or AMR, occurs when microorganisms such as bacteria, change over time and no longer respond to antibiotics. The result is that infections become harder to treat and common medical interventions become riskier.

For Luna Parry, who works across Palladium’s AMR portfolio, its relative invisibility is part of what makes the threat so urgent. “AMR is a silent pandemic,” she says. “It’s a real threat, but it’s not talked about enough.”

World AMR Awareness Week (WAAW) is an opportunity to change that, but also to focus attention on what happens after awareness. Across Palladium’s AMR work, that means helping countries turn surveillance into decisions, strengthen laboratory and stewardship systems, coordinate across One Health sectors and increasingly lead and finance their own response.

From Global Commitment to Country Ownership

International attention to AMR has grown considerably over the past decade. In 2024, global leaders made new commitments to tackle antimicrobial resistance at the United Nations General Assembly.

But AMR does not respect the traditional boundaries of the health sector. Resistant pathogens can emerge and spread between people, animals and the environment, demanding a One Health response that brings these different systems together.

“AMR and global health security come hand in hand,” says Parry.

That is particularly important at a moment when overseas aid budgets are under pressure. Previous investments have helped countries build surveillance networks, laboratories, data systems and national coordination mechanisms. Protecting those gains increasingly requires embedding them into existing institutions and strategies rather than creating systems that depend indefinitely on external funding.

Palladium is delivering support through existing health programmes in Africa and Asia, including Lafiya in Nigeria, Tackling Deadly Diseases in Africa Programme 2 (TDDAP2) across five African countries, and Evidence for Health in Pakistan.

“The breadth matters,” Parry says. “We’re pursuing the AMR agenda across very different country contexts.”

Turning Surveillance into Action

In Uganda, the challenge is no longer simply generating AMR data. The government has established surveillance mechanisms across human, animal and environmental sectors, but information remains distributed across different systems and reporting platforms.

TDDAP2 is working with government to improve the integration and practical use of that information. A One Health workshop in Jinja in September brought representatives from all three sectors together, starting not with the available data, but with the decisions it needs to inform. Those include reviewing treatment guidelines, using AMR information in procurement planning and improving environmental monitoring.

It is a deceptively simple shift: begin with the decision, then build the data flow around it.

Ghana is tackling the same challenge from another angle. Through TDDAP2, staff have been supported to strengthen surveillance at fish farms and slaughterhouses in Greater Accra, including the collection of 145 samples. Ninety farmers in the Western and Eastern Regions have strengthened their knowledge of antimicrobial consumption, biosecurity and data collection. The programme has also supported development of Ghana’s National One Health AMR Report.

During WAAW, Ghana plans to convene government, academia, communities, civil society and the private sector for national dialogue, alongside the planned launch of the National One Health AMR Report, National AMR Surveillance Strategy and Integrated One Health Framework.

Building Systems that Can Last

In Malawi, Palladium’s work demonstrates what institutionalising the AMR response can look like in practice.

TDDAP2, working with the Ministry of Health and UK Health Security Agency, has helped develop a national bacteriology mentorship strategy and train 15 laboratory mentors. The programme is preparing for rollout across 19 laboratory facilities, creating a structure through which laboratory skills can continue to be strengthened over time. Malawi has also developed its first dedicated AMR training module for Community Health Workers.

For WAAW, Malawi plans to launch an AMR Community of Practice webinar series, disseminate national surveillance reports and an AMR bulletin, and share findings from an assessment of opportunities to better integrate AMR data into routine systems.

Nigeria illustrates the financial stakes of this transition. While the country has invested in laboratories, susceptibility testing, quality management and surveillance, continued operations require equipment maintenance, reagents, data management and reliable reporting. Through Lafiya, Palladium is providing embedded technical assistance focused on 10 priority human-health sentinel surveillance sites spanning Nigeria’s six geopolitical zones.

The programme is also helping translate AMR priorities into costed actions, including development of an investment case and resource mobilisation strategy and efforts to incorporate priorities into government operational plans and financing mechanisms.

During WAAW, Lafiya plans to support government partners with One Health awareness and advocacy, engagement at selected sentinel sites and outreach to health workers, veterinarians, farmers, students and communities. Crucially, the campaign will also engage policymakers and budget authorities on financing and implementation commitments.

Awareness is the Beginning

WAAW offers a moment to make an invisible threat visible. But across the countries where Palladium is working, awareness is increasingly connected to a bigger question: who will own and sustain the response?

“Countries are publicly committing to continue the work and fight AMR,” says Parry and that commitment translates into the less visible infrastructure behind an effective response: functioning laboratories, connected information systems, trained laboratory and health workers, cross-sector coordination and budgets that can sustain them.

AMR will not be addressed through a single campaign or programme. The opportunity now is to ensure that the capacity built through years of investment becomes part of routine national systems, enabling countries to detect resistance earlier and more effectively, act on the evidence and sustain their response for the long term.

That is how awareness becomes action, and how action becomes resilience.